• Mutation; HGNC; HGNC:171; ACVR1; Simple; p.Arg206His (c.617G>A); ClinVar=VCV000018309; Zygosity=Unspecified (PubMed=27325687).
  
• Mutation; HGNC; HGNC:4764; H3-3A; Simple; p.Lys28Met (c.83A>T) (H3.3K27M); ClinVar=VCV000376435; Zygosity=Unspecified (PubMed=27325687; PubMed=34732238).
  
• Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Pro428Glnfs*3 (c.1283delC); Zygosity=Unspecified (PubMed=32229503; PubMed=34732238).
  

PubMed=25628092; DOI=10.1038/bjc.2015.16; PMCID=PMC4333505
Julia V. Cockle, Susan Picton, Jane Levesley, Elizabeth Jane Ilett, Angel Montero Carcaboso, Susan Short, L.P. Steel, Alan Melcher, Sean E. Lawler, Anke Bruning-Richardson;
Cell migration in paediatric glioma; characterisation and potential therapeutic targeting.
Br. J. Cancer 112:693-703(2015)

PubMed=27325687; DOI=10.1158/1535-7163.MCT-15-0558
Marc H.A. Jansen, Tonny Lagerweij, A. Charlotte P. Sewing, Danielle J. Vugts, Dannis G. van Vuurden, Carla F.M. Molthoff, Viola Caretti, Susanna J.E. Veringa, Naomi Petersen, Angel Montero Carcaboso, David Pieter Noske ...Show all 16 authors... , William Peter Vandertop, Pieter Wesseling, Guus A.M.S. van Dongen, Gertjan J.L. Kaspers, Esther Hulleman; Show fewer authors
Bevacizumab targeting diffuse intrinsic pontine glioma: results of 89Zr-bevacizumab PET imaging in brain tumor models.
Mol. Cancer Ther. 15:2166-2174(2016)

PubMed=28947132; DOI=10.1016/j.yexcr.2017.09.032
Michael Hananja Meel, A. Charlotte P. Sewing, Piotr Waranecki, Dennis S. Metselaar, Laurine E. Wedekind, Jan Koster, Dannis G. van Vuurden, Gertjan J.L. Kaspers, Esther Hulleman;
Culture methods of diffuse intrinsic pontine glioma cells determine response to targeted therapies.
Exp. Cell Res. 360:397-403(2017)

PubMed=31439867; DOI=10.1038/s41467-019-11732-6; PMCID=PMC6706443
Nathan R. Fons, Ranjini K. Sundaram, Gregory A. Breuer, Sen Peng, Ryan L. McLean, Aravind N. Kalathil, Mark S. Schmidt, Diana M. Carvalho, Alan Mackay, Chris Jones, Angel Montero Carcaboso ...Show all 15 authors... , Javad Nazarian, Michael E. Berens, Charles Brenner, Ranjit S. Bindra; Show fewer authors
PPM1D mutations silence NAPRT gene expression and confer NAMPT inhibitor sensitivity in glioma.
Nat. Commun. 10:3790.1-3790.10(2019)

PubMed=32229503; DOI=10.1158/1541-7786.MCR-19-0507
Zhao-Hui Wang, Cheng Xu, Bill H. Diplas, Casey Joseph Moure, Chin-Pu Jason Chen, Lee H. Chen, Chang-Zheng Du, Hui-Shan Zhu, Paula K. Greer, Li-Wei Zhang, Yi-Ping He ...Show all 13 authors... , Matthew S. Waitkus, Hai Yan; Show fewer authors
Targeting mutant PPM1D sensitizes diffuse intrinsic pontine glioma cells to the PARP inhibitor olaparib.
Mol. Cancer Res. 18:968-980(2020)

PubMed=34078608; DOI=10.1126/sciadv.abg4126; PMCID=PMC10166578
Juan Wang, Tina Yi-Ting Huang, Ye Hou, Elizabeth Thomas Bartom, Xin-Yan Lu, Ali Shilatifard, Feng Yue, Amanda Muhs Saratsis;
Epigenomic landscape and 3D genome structure in pediatric high-grade glioma.
Sci. Adv. 7:eabg4126.1-eabg4126.16(2021)

PubMed=34732238; DOI=10.1186/s40478-021-01270-y; PMCID=PMC8565061
Cheng Xu, Heng Liu, Christopher J. Pirozzi, Lee H. Chen, Paula K. Greer, Bill H. Diplas, Li-Wei Zhang, Matthew S. Waitkus, Yi-Ping He, Hai Yan;
TP53 wild-type/PPM1D mutant diffuse intrinsic pontine gliomas are sensitive to a MDM2 antagonist.
Acta Neuropathol. Commun. 9:178.1-178.12(2021)